Clinical Trial Update: Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women [Phase 2]

View source ↗

Summary

Phase 2 study evaluating a co-formulated vaginal suppository containing metronidazole and miconazole to prevent vaginal infections in HIV-seronegative women. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis
• Candidiasis
• Trichomoniasis

Drugs mentioned

• METRONIDAZOLE (Metronidazole)
• Miconazole (miconazole)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Bacterial Vaginosis, Candidiasis | Phase 2 | Status: COMPLETED | Results posted: 2014-09-26